Medimaps Group

Plan-les-Ouates, Switzerland

Medimaps Group is a leading global medical software analytics company founded by a group of clinical practitioners and researchers, based in Switzerland with offices in the US and in France. It specializes in the engineering, research, development, and commercialization of medical software applications based on patented multi-purpose technologies.Its flagship product, the TBS iNsight™ (Osteo) software application has been used for years in over 75 countries in clinical practice to better predict fracture risk in the field of primary and secondary osteoporosis (e.g. in patients with diabetes, hyperparathyroidism, CKD, HIV, and GIO). The maximal impact of the TBS score is observed in patients with osteopenic BMD values who display low TBS scores and consequently have a higher combined risk profile; in patients whose fracture risk is close to the FRAX ® intervention thresholds; and in secondary osteoporosis.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Medimaps Group on @MedStartr Today #MedMo #MedStartrVentures

https://www.medstartr.ai/s/j3fW7nJBT4U

Get Involved in Medimaps Group

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2006
Website: medimaps.ai/

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Medimaps Group?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.

Get Involved in Medimaps Group